dipyridamole has been researched along with Atrioventricular Block in 4 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Atrioventricular Block: Impaired impulse conduction from HEART ATRIA to HEART VENTRICLES. AV block can mean delayed or completely blocked impulse conduction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Adenosine and related compounds have been shown to produce atrioventricular (AV) conduction block during acute myocardial ischemia." | 7.78 | Effects of the antianginal drug trapidil on atrioventricular conduction disturbances during acute myocardial ischemia. ( Hirayama, A; Kasamaki, Y; Kofune, M; Mano, H; Nagashima, K; Ohkubo, K; Okumura, Y; Sonoda, K; Watanabe, I, 2012) |
| "Adenosine and related compounds have been shown to produce atrioventricular (AV) conduction block during acute myocardial ischemia." | 3.78 | Effects of the antianginal drug trapidil on atrioventricular conduction disturbances during acute myocardial ischemia. ( Hirayama, A; Kasamaki, Y; Kofune, M; Mano, H; Nagashima, K; Ohkubo, K; Okumura, Y; Sonoda, K; Watanabe, I, 2012) |
| "Adenosine was incrementally dosed until AV block occurred (maximum 200 mcg/kg up to 12 mg)." | 2.94 | Impact of dipyridamole on adenosine dosing in pediatric and young adult patients after heart transplantation. ( Addonizio, LJ; Anderson, BR; Flyer, JN; Liberman, L; Richmond, ME; Satzer, MB; Silver, ES; Zuckerman, WA, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Satzer, MB | 1 |
| Flyer, JN | 1 |
| Zuckerman, WA | 1 |
| Liberman, L | 1 |
| Richmond, ME | 1 |
| Anderson, BR | 1 |
| Addonizio, LJ | 1 |
| Silver, ES | 1 |
| Massalha, S | 1 |
| Reizberg, I | 1 |
| Israel, O | 1 |
| Kapeliovich, M | 1 |
| Sholy, H | 1 |
| Koskosi, A | 1 |
| Keidar, Z | 1 |
| Marai, I | 1 |
| Watanabe, I | 1 |
| Okumura, Y | 1 |
| Nagashima, K | 1 |
| Kofune, M | 1 |
| Ohkubo, K | 1 |
| Mano, H | 1 |
| Sonoda, K | 1 |
| Kasamaki, Y | 1 |
| Hirayama, A | 1 |
| GONZALEZ MENENDEZ, E | 1 |
1 trial available for dipyridamole and Atrioventricular Block
| Article | Year |
|---|---|
Impact of dipyridamole on adenosine dosing in pediatric and young adult patients after heart transplantation.
Topics: Adenosine; Adolescent; Anti-Arrhythmia Agents; Atrioventricular Block; Child; Child, Preschool; Dipy | 2020 |
3 other studies available for dipyridamole and Atrioventricular Block
| Article | Year |
|---|---|
Conduction abnormalities during dipyridamole stress testing.
Topics: Atrioventricular Block; Bradycardia; Causality; Comorbidity; Coronary Artery Disease; Dipyridamole; | 2017 |
Effects of the antianginal drug trapidil on atrioventricular conduction disturbances during acute myocardial ischemia.
Topics: Adenosine; Angina Pectoris; Animals; Atrioventricular Block; Atrioventricular Node; Bundle of His; D | 2012 |
[Incomplete AV block. Further aspects of its therapy].
Topics: Adrenal Cortex Hormones; Atrioventricular Block; Cardiovascular Diseases; Dipyridamole; Heart Block; | 1963 |